June 2013

Use of antimüllerian hormone: the risks of interpreting ovarian reserve markers in isolation

Reflections on “Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimüllerian hormone” by Toner et al.
Published
Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine
Like

Authors

Zev Rosenwaks, M.D., David E. Reichman, M.D.

Volume 99, Issue 7, Pages 1850, June 2013

Abstract

Reflections on “Why we may abandon basal follicle-stimulating hormone testing: A sea change in determining ovarian reserve using antimüllerian hormone” by Toner et al.

Read the full text at: http://www.fertstert.org/article/S0015-0282(13)00452-4/fulltext


Go to the profile of Fertility and Sterility
Fertility and Sterility
Editorial Office, American Society for Reproductive Medicine

Fertility and Sterility® is an international journal for obstetricians, gynecologists, reproductive endocrinologists, urologists, basic scientists and others who treat and investigate problems of infertility and human reproductive disorders. 

Recommended Content